Skip to main content
. 2012 Jul 10;74(2):304–314. doi: 10.1111/j.1365-2125.2012.04198.x

Figure 6.

Figure 6

Pharmacokinetic profiles for ketamine and corresponding metabolites in a representative subject; (A) ketamine, (B) norketamine, (C) dehydronorketamine, and (D) (2S,6S)-/(2R,6R)-HNK. Red circles are measured (S)-enantiomer concentrations, blue circles are measured (R)-enantiomer concentrations and continuous lines are model fitted profiles